Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false question first answered
creator	label
publisher	pref label
tabling member	label

Search

1139311

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:29:23
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:38:53 26/07/2019 11:47:02
	hansard heading	Asthma: Health Services
	house id	1
	identifier	277746
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/07/2019 11:15:34
	question text	To ask the Secretary of State for Health and Social Care, with reference to the publication of three regulation 28 (Prevention of Future Death) Reports on asthma deaths, what steps he is taking to ensure that severe asthma sufferers are referred to specialist services.
	session	2017/19
	session number	1
	tabling member constituency	Barnsley Central
	tabling member printed	Dan Jarvis
	title	House of Commons Tabled Parliamentary Question 2017/19 277746
	type	WrittenParliamentaryQuestion
	uin	277746
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 26/07/2019 11:15:34
	creator	4243 label Biography information for Dan Jarvis
	publisher	25259 pref label House of Commons
	tabling member	4243 label Biography information for Dan Jarvis

1139230

	human indexable
	published
	registered interest
	answer date	22/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:25:56
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	17/07/2019 14:45:13 22/07/2019 16:41:06
	hansard heading	Attention Deficit Hyperactivity Disorder: Diagnosis
	house id	1
	identifier	277852
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	22/07/2019 16:09:22
	question text	To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health and Social Care of 15 May 2018, Official Report, column 111WH, what progress has been made in discussions with NHS Digital on what data can be made accessible via the mental health dataset waiting times for attention deficit hyperactivity disorder assessments.
	session	2017/19
	session number	1
	tabling member constituency	Leigh
	tabling member printed	Jo Platt
	title	House of Commons Tabled Parliamentary Question 2017/19 277852
	type	WrittenParliamentaryQuestion
	uin	277852
	version	2
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction question first answered 22/07/2019 16:09:22
	creator	4673 label Biography information for Jo Platt
	publisher	25259 pref label House of Commons
	tabling member	4673 label Biography information for Jo Platt

1138859

	human indexable
	published
	registered interest
	answer date	17/07/2019
	date	15/07/2019
	date tabled	15/07/2019
	ddp created	15/07/2019 18:41:15
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/07/2019 18:57:00 23/07/2019 16:38:04
	hansard heading	Genetics: Screening
	house id	1
	identifier	277243
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	23/07/2019 16:06:02
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Clinical Advisory Group for Genomics, if he will set out (a) its terms of reference, (b) when it will first meet, (c) how patient voice will be incorporated into its work, (d) who it will report to and (e) when the (i) Commissioning Policy for Preimplantation Genetic Diagnosis review and (ii) other work of its predecessor, the Clinical Reference Group for Medical Genetics, will be completed; and if he will make a statement.
	session	2017/19
	session number	1
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	title	House of Commons Tabled Parliamentary Question 2017/19 277243
	type	WrittenParliamentaryQuestion
	uin	277243
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 23/07/2019 16:06:02
	creator	4523 label Biography information for Catherine West
	publisher	25259 pref label House of Commons
	tabling member	4523 label Biography information for Catherine West

1139442

	human indexable
	published
	registered interest
	answer date	22/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:34:38
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:43:37 22/07/2019 16:18:06
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	277757
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	22/07/2019 15:46:12
	question text	To ask the Secretary of State for Health and Social Care, with reference to the 2019 Voluntary Scheme for Branded Medicines Pricing and Access, how many opportunities there have been for pharmaceutical industry trade bodies to input into NHS England’s commercial framework; and what steps the Government is taking to secure the participation of industry trade bodies.
	session	2017/19
	session number	1
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2017/19 277757
	type	WrittenParliamentaryQuestion
	uin	277757
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction question first answered 22/07/2019 15:46:12
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1139227

	human indexable
	published
	registered interest
	answer date	22/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:25:45
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:35:39 22/07/2019 16:46:03
	hansard heading	Loneliness
	house id	1
	identifier	277688
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	22/07/2019 16:14:09
	question text	To ask the Secretary of State for Health and Social Care, with reference to the 2018 Loneliness Strategy, what steps his Department has taken to work with the Loneliness Action Group to share learning on loneliness and ensure effective implementation of the strategy.
	session	2017/19
	session number	1
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	title	House of Commons Tabled Parliamentary Question 2017/19 277688
	type	WrittenParliamentaryQuestion
	uin	277688
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction question first answered 22/07/2019 16:14:09
	creator	1533 label Biography information for Dame Diana Johnson
	publisher	25259 pref label House of Commons
	tabling member	1533 label Biography information for Dame Diana Johnson

1139199

	human indexable
	published
	registered interest
	answer date	22/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:24:28
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:25:37 22/07/2019 16:05:04
	hansard heading	NHS: Pay
	house id	1
	identifier	277749
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	22/07/2019 15:33:16
	question text	To ask the Secretary of State for Health and Social Care, with reference to paragraph 170 of his Department's Annual Report 2018-19 on the increased NHS resource budget and to the Written Statement on NHS Workforce made on 21 March 2018, HCWS574, if he will clarify when the additional £4.2 billion was agreed by the Chancellor for the NHS Agenda for Change three year pay deal.
	session	2017/19
	session number	1
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	title	House of Commons Tabled Parliamentary Question 2017/19 277749
	type	WrittenParliamentaryQuestion
	uin	277749
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction question first answered 22/07/2019 15:33:16
	creator	4244 label Biography information for Jonathan Ashworth
	publisher	25259 pref label House of Commons
	tabling member	4244 label Biography information for Jonathan Ashworth

1139443

	human indexable
	published
	registered interest
	answer date	22/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:34:41
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:43:40 22/07/2019 16:16:06
	hansard heading	NHS: Drugs
	house id	1
	identifier	277758
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	22/07/2019 15:44:39
	question text	To ask the Secretary of State for Health and Social Care, with reference to his oral evidence at the Health and Social Care Committee on 9 July 2019, what the expiration date is for the options on the additional transport capacity for medicines; what the timescales are for exercising those options; and what the cost to the Department will be if those options are not exercised.
	session	2017/19
	session number	1
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2017/19 277758
	type	WrittenParliamentaryQuestion
	uin	277758
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction question first answered 22/07/2019 15:44:39
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1139444

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:34:43
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:43:42 23/07/2019 16:01:01
	hansard heading	NHS: Drugs
	house id	1
	identifier	277759
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	23/07/2019 15:30:00
	question text	To ask the Secretary of State for Health and Social Care, with reference to his oral evidence at the Health and Social Care Committee on 9 July 2019, if he will place in the Library his Department’s latest assessment of (a) the appropriate level of warehousing capacity required for stockpiling medicines and (b) the flow assumptions of importing medicines in the event that the UK leaves the EU without a deal.
	session	2017/19
	session number	1
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2017/19 277759
	type	WrittenParliamentaryQuestion
	uin	277759
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 23/07/2019 15:30:00
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1139371

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:31:49
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:41:01 23/07/2019 17:15:02
	hansard heading	HIV Infection: Drugs
	house id	1
	identifier	277726
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	23/07/2019 16:43:55
	question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to include women who are at risk of contracting HIV in the PrEP impact trial.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277726
	type	WrittenParliamentaryQuestion
	uin	277726
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 23/07/2019 16:43:55
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1139220

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:25:21
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:35:24 25/07/2019 10:32:04
	hansard heading	Medical Devices (Amendment etc.) (EU Exit) Regulations 2019
	house id	1
	identifier	277764
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	25/07/2019 10:00:04
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to seek an extension to the implementation period of the Medical Devices Regulation from the EU.
	session	2017/19
	session number	1
	tabling member constituency	Bolton West
	tabling member printed	Chris Green
	title	House of Commons Tabled Parliamentary Question 2017/19 277764
	type	WrittenParliamentaryQuestion
	uin	277764
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 25/07/2019 10:00:04
	creator	4398 label Biography information for Chris Green
	publisher	25259 pref label House of Commons
	tabling member	4398 label Biography information for Chris Green